Journal of Pathology and Translational Medicine10.4132/jptm.2017.10.20201852137-44The Smad4/PTEN Expression Pattern Predicts Clinical Outcomes in Colorectal AdenocarcinomaYumin Chung, Young Chan Wi, Yeseul Kim, Seong Sik Bang, Jung-Ho Yang, Kiseok Jang, Kyueng-Whan Min, Seung Sam Paik,,
International Journal of Urology10.1111/iju.12571201421121209-1214PTEN loss in biopsy tissue predicts poor clinical outcomes in prostate cancerPrabhakar Mithal, Emma Allott, Leah Gerber, Julia Reid, William Welbourn, Eliso Tikishvili, Jimmy Park, Adib Younus, Zaina Sangale, Jerry S Lanchbury, Steven Stone, Stephen J Freedland
Oncogene10.1038/onc.2009.3752009295674-686Synergistic action of Smad4 and Pten in suppressing pancreatic ductal adenocarcinoma formation in miceX Xu, B Ehdaie, N Ohara, T Yoshino, C -X Deng,,
Clinical Colorectal Cancer10.3816/ccc.2011.n.003201110124-29Prognostic Value of Reduced SMAD4 Expression in Patients With Metastatic Colorectal Cancer Under Oxaliplatin-Containing Chemotherapy: A Translational Study of the AIO Colorectal Study GroupAlexander Baraniskin, Johanna Munding, Karsten Schulmann, Dominik Meier, Rainer Porschen, Hendrik-Tobias Arkenau, Ullrich Graeven, Wolff Schmiegel, Andrea Tannapfel, Anke Reinacher-Schick,
PLOS ONE10.1371/journal.pone.01782752017125e0178275Correction: Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer
Clinical Colorectal Cancer10.1016/s1533-0028(11)70123-2200444249-251Small Bowel AdenocarcinomaShivaani Kummar,
IUBMB Life10.1002/iub.17552018 USP4 expression independently predicts favorable survival in lung adenocarcinomaMing Zhong, Qi Jiang, Ronghui Jin,
FEBS Letters10.1016/s0014-5793(02)03777-820025331110-114Gene expression monitoring accurately predicts medulloblastoma positive and negative clinical outcomesMichael J Korenberg
Clinical Colorectal Cancer10.1016/j.clcc.2017.10.013201817125-31Autophagy Inhibition in Pancreatic AdenocarcinomaBrian A. Boone, Herbert J. Zeh, Nathan Bahary,
Clinical Biochemistry10.1016/j.clinbiochem.2016.11.0342017506285-292Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinomaDimitrios Kerimis, Christos K. Kontos, Spyridon Christodoulou, Iordanis N. Papadopoulos, Andreas Scorilas,